Company / Free Cash Flow per Share
Bristol Myers Squibb Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$6.18
FY2025
5-year range
$4.31 / $6.79
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
#16 of 192
Health Care
What the data says
Among 192 Health Care companies, Bristol Myers Squibb is in the top 8% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $1.10 in FY2018 to $8.12 in FY2020.
Based on SEC 10-K filings.
6.18 in FY2025 with a 5-year CAGR of -5.3%. Top quartile in the Health Care sector.
Declined from $6.79 to $6.18 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
+131.2% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 4.9% year-over-year.
- Ranks #16 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.18 | -4.9% |
| FY2024 | $6.50 | -4.3% |
| FY2023 | $6.79 | +15.2% |
| FY2022 | $5.89 | +36.7% |
| FY2021 | $4.31 | -47.0% |
| FY2020 | $8.12 | +218.0% |
| FY2019 | $2.55 | +132.9% |
| FY2018 | $1.10 | -56.4% |
| FY2017 | $2.51 | +60.1% |
| FY2016 | $1.57 | -13.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026